5Adams CP,Brantner VV. Estimating the cost of new drug development:is it really $802 million[J]. Health Aff,2006,25(2):420-428.
6DiMasi JA. The value of improving the productivity of the drug development process:faster times and better decisions[J]. Pharmacoeconomies, 2002,20 ( Suppl3 ) : S 1 10.
7赵宁志.加强军队医院药学工作的几点措施.解放军卫勤杂志,2008,:312-313.
8Janice KB, Wanju SD, Gretchen SD, et al . The Artand Science of Risk Management[ J]. Drug Safety,2006,28 ( 1 ) : 1 - 18.
9Newm BY. Drug interactions Reducing the risk [ J ]. Optometry - Journal of the Am erican optometric Association ,2007,78 ( 8 ) :385 - 386.
3Mayhew R,McKoy JM,Ha Luu T,et al.Adverse drug interactions:moving from perception to action[J].Pharmacoeconomics,2010,28(1):19.
4Sculpher MJ,Drummond MF.Analysis sans frontieres:can we ever make economic evaluations generalisable across jurisdictions?[J].Pharmacoeconomics,2006,24(11):1087.
